Untargeted metabolomics unravels functionalities of phosphorylation sites in 
                   by unknown
RESEARCH ARTICLE Open Access
Untargeted metabolomics unravels
functionalities of phosphorylation sites in
Saccharomyces cerevisiae
Zrinka Raguz Nakic1,2, Gerhard Seisenbacher3, Francesc Posas3 and Uwe Sauer1*
Abstract
Background: Coordinated through a complex network of kinases and phosphatases, protein phosphorylation
regulates essentially all cellular processes in eukaryotes. Recent advances in proteomics enable detection of
thousands of phosphorylation sites (phosphosites) in single experiments. However, functionality of the vast majority
of these sites remains unclear and we lack suitable approaches to evaluate functional relevance at a pace that
matches their detection.
Results: Here, we assess functionality of 26 phosphosites by introducing phosphodeletion and phosphomimic mutations
in 25 metabolic enzymes and regulators from the TOR and HOG signaling pathway in Saccharomyces cerevisiae by
phenotypic analysis and untargeted metabolomics. We show that metabolomics largely outperforms growth analysis and
recovers 10 out of the 13 previously characterized phosphosites and suggests functionality for several novel sites,
including S79 on the TOR regulatory protein Tip41. We analyze metabolic profiles to identify consequences underlying
regulatory phosphorylation events and detecting glycerol metabolism to have a so far unknown influence on arginine
metabolism via phosphoregulation of the glycerol dehydrogenases. Further, we also find S508 in the MAPKK Pbs2 as a
potential link for cross-talking between HOG signaling and the cell wall integrity pathway.
Conclusions: We demonstrate that metabolic profiles can be exploited for gaining insight into regulatory consequences
and biological roles of phosphosites. Altogether, untargeted metabolomics is a fast, sensitive and informative approach
appropriate for future large-scale functional analyses of phosphosites.
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Background
Adaptation to changes in the environment is crucial for
the survival of any organism and adjustment of protein
levels and activities is pivotal for this process. Long-term
adaptations via (post-)transcriptional regulation or irre-
versible protein modification typically affect protein
abundance. Fast adaptations are mediated by allosteric
regulators and a chemically diverse group of covalent
post-translational modifications (PTMs). In eukaryotes,
phosphorylation stands out among PTMs for the broad
scope of regulation and the complexity of its network
with over 160 known kinases and phosphatases in
Saccharomyces cerevisiae [1]. Recent advances in
proteomics allow for deep interrogation of phosphopro-
teomes, leading to large catalogues of phosphorylation
sites (phosphosites) in different species [2–4], suggesting
that as many as 45% of all proteins in eukaryotes may be
phosphorylated [5]. While the number of mapped phos-
phosites is ever increasing, we still rarely know whether
phosphorylation events have a functional role. A sub-
stantial fraction of all phosphosites was suggested to be
non-functional, resulting from stochastic off-target kin-
ase activity [6, 7]. Typically, only a handful of all
observed phosphosites in any organism has been func-
tionally validated and characterized [5, 8] because the
success in phosphoproteomics in detecting phosphosites
has largely outpaced the performance and throughput of
the available approaches for analysis of phosphosites
functionality.
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Present workflows for functional analysis of phospho-
sites typically start with phosphoproteomics to generate
catalogues of modified amino acids. Computational
approaches then distinguish between relevant and non-
functional phosphosites on the basis of different criteria
including kinase recognition motives [9, 10], conserva-
tion patterns of phosphosites across species [6, 7],
correlations of changes in phosphorylation state with
metabolic flux [11], or temporal patterns of phosphosite
appearances upon disturbance [12]. After prioritization
of interesting phosphosites, their functionality remains
to be determined in laborious follow-up experiments.
Typically, these experiments take advantage of site spe-
cific phosphosite mutants and include a combination of
phosphorylation assays, growth and viability assays,
localization studies, expression studies and enzymatic in
vitro assays [13–20]. Targeted measurements of intracel-
lular metabolites have been used in some cases to inves-
tigate phosphoregulation of metabolism [11, 16, 20]. All
these methods have been powerful in elucidating the im-
portance of single phosphosites. However, they are not
suitable for high throughput analysis as the readout of
most approaches is specific to the investigated protein
and would imply tedious laboratory work to make them
applicable in larger scale. Although growth and viability
assays allow high throughput, their sensitivity for asses-
sing functionality is unclear. Given that phosphorylation
often only fine-tunes the activity of a protein, interfering
with phosphorylation might not necessarily penetrate to
the phenotypic level.
The recent developments in genome editing render
the generation of large numbers of mutants with modi-
fied phosphosites for functional analysis feasible [21–24].
Hence, the limitation shifts to a suitable high throughput
approach for subsequent mutant analysis, in particular
when phenotypes are more subtle, as can be expected
for most point mutations. In principle the various omics
technologies would be applicable, but in practice they
are typically too laborious or expensive. A notable
exception is mass spectrometry-based metabolomics. In
particular, it offers the potential to identify small differ-
ences in metabolite profiles well before a change of the
phenotype is observed [25, 26]. Since many of the
phosphoproteins listed in phosphosite databases are part
of the metabolic network, metabolomics is a promising
approach for probing their functionality.
Here we investigate the potential of untargeted
metabolomics for higher throughput identification and
characterization of phosphosite functionality. We intro-
duced pointmutations into 26 phosphosites from 25 pro-
teins in S. cerevisiae, several of which were known to be
functionally regulated by phosphorylation. The proteins
included metabolic enzymes and regulatory proteins
implicated in the TOR or HOG signaling, two pathways
closely related to metabolism [27–29]. The phosphoresi-
dues were mutated to amino acids that mimic a con-
stitutively dephosphorylated and, for a selected subset,
phosphorylated state, resulting in a total of 32 phos-
phomutants. Applying untargeted metabolomics, we
retrieved most previously characterized phosphoproteins
as functionally relevant and suggest functionality for
additional phosphosites. We also showed that untargeted
metabolomics aids in unveiling the biological roles of
functional phosphosites in regulating metabolic path-
ways. Our results demonstrate that untargeted metabo-
lomics is a highly sensitive method for high throughput
detection of functionalities of phosphosites.
Results
Phenotypic analysis reveals functionalities of strong-impact
phosphosites
For the purpose of defining a set of phosphomutants for
phenotypic and metabolic analysis, we selected single
phosphosites or multiple phosphosites in close proximity
(hereafter jointly termed as phosphosites) on metabolic
enzymes or proteins involved in TOR or HOG signaling.
The 26 chosen phosphosites were located on 25 proteins
that represent different functional classes, such as meta-
bolic enzymes, kinases or transcription factors (Table 1
and Additional file 1). The two signaling pathways were
selected for their metabolic function, rendering them
amenable for a metabolomics approach. TOR signaling
controls the cellular response to nitrogen availability,
having a substantial impact on the state of metabolism
when metabolizing nitrogen sources of different quality
[27, 29]. The main role of the HOG signaling pathway is
sensing of extracellular hyperosmolarity and eliciting a
stress response, which in S. cerevisiae primarily consists of
a metabolic adaptation to increase the concentration of
the osmolyte glycerol together with cell cycle and tran-
scriptional modulation [28]. The total set of the 26 phos-
phosites contained 13 functionally characterized and 13
uncharacterized phosphosites. We classified phosphosites
as characterized when a phosphosite mutant has been re-
ported to have an effect in any type of functional analysis.
Most uncharacterized phosphosites were selected based
on differential phosphorylation data from phosphoproteo-
mics studies in either different growth conditions or upon
kinase deletion [4, 11, 30] (Additional file 1). The chosen
phosphosites were mutated to alanine whenever serine or
threonine was the phosphoresidue, or phenylalanine if
tyrosine was the phosphoresidue, thereby abolishing phos-
phorylation of the target amino acid (Table 1). For six out
of the 26 phosphosites the residues were additionally
mutated to glutamic acid to mimic a constitutively phos-
phorylated state of the protein, resulting in a total of 32
mutants. Throughout this study, mutants with abolished
phosphorylation are referred to as “OUT” mutants, while
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phosphomimic mutants are referred to as “IN” mutants.
Up to three independent mutant replicates per phospho-
site were generated (Additional file 1). Phosphomutant
replicates with broad metabolic effects exhibited highly
similar metabolic profiles (Additional file 2: Figure S1),
suggesting that genetic manipulations were precise.
To identify condition-specific regulation, the 32 phospho-
mutants were grown on four combinations of carbon and
nitrogen sources that require different activities of the mu-
tated proteins, such as glycolytic or gluconeogenic fluxes,
nitrogen sources of different quality, and low osmotic stress
on 0.22 M sodium pyruvate (Table 2). We quantified
growth rates and maximum cell density and qualitatively
assessed lag times and other abnormalities in the growth
curves of microtiter plate cultures (Fig. 1a and Additional
file 3). Six mutants in four different phosphosites exhibited
an aberrant phenotype under at least one condition
(Fig. 1b). Three of these phosphosites were already previ-
ously characterized, but functionality of the Tip41 phospho-
site was hitherto unknown. The phosphomutants of Pda1

















Crz1 YNL027W 409, 410, 423, 427, 429 p-deletion Crz1 OUT TF HOG pathway ch [38, 61]
Cys3 YAL012W 39, 40 p-deletion Cys3 OUT Enzyme metabolic enzyme dif [11, 30]
Gln3 YER040W 469, 471, 473 p-deletion Gln3 site 1 OUT TF TOR signaling dif [4, 11]
Gln3 YER040W 469 p-deletion Gln3 site 2 OUT TF TOR signaling dif [4, 11]
Gpd1 YDL022W 24, 27 p-deletion Gpd1 OUT Enzyme metabolic enzyme ch [11, 20]
Gpd2 YOL059W 72, 75 p-deletion Gpd2 OUT Enzyme metabolic enzyme ch [20]
Gut1 YHL032C 96 p-deletion Gut1 OUT Enzyme metabolic enzyme dif [11]
Hog1 YLR113W 174, 176 p-deletion Hog1 OUT Kinase HOG pathway ch [31, 62]
Lys20 YDL182W 395, 396 p-deletion Lys20 OUT Enzyme metabolic enzyme ch [4, 11, 26]
Nbp2 YDR162C 194, 196 p-deletion Nbp2 OUT Adapter HOG pathway dif [4, 30]
Nbp2 YDR162C 194, 196 p-mimic Nbp2 IN Adapter HOG pathway dif [4, 30]
Pbs2 YJL128C 508 p-deletion Pbs2 OUT Kinase HOG pathway ch [15]
Pbs2 YJL128C 508 p-mimic Pbs2 IN Kinase HOG pathway ch [15]
Pda1 YER178W 313 p-deletion Pda1 OUT Enzyme metabolic enzyme ch [63]
Pda1 YER178W 313 p-mimic Pda1 IN Enzyme metabolic enzyme ch [63]
Pfk1 YGR240C 895 p-deletion Pfk1 OUT Enzyme metabolic enzyme dif [4, 11]
Pfk2 YMR205C 163 p-deletion Pfk2 OUT Enzyme metabolic enzyme difa [4, 11]
Pfk2 YMR205C 163 p-mimic Pfk2 IN Enzyme metabolic enzyme difa [4, 11]
Put3 YKL015W 788 p-deletion Put3 OUT TF TOR signaling ch [18]
Rim15 YFL033C 1061 p-deletion Rim15 OUT Kinase TOR signaling ch [64]
Rim15 YFL033C 1061 p-mimic Rim15 IN Kinase TOR signaling ch [64]
Sko1 YNL167C 108, 113, 126 p-deletion Sko1 OUT TF HOG pathway ch [65]
Smp1 YBR182C 348, 357, 365, 376 p-deletion Smp1 OUT TF HOG pathway ch [66]
Ste50 YCL032W 202 p-deletion Ste50 OUT Adapter HOG pathway ch [37]
Str3 YGL184C 456 p-deletion Str3 OUT Enzyme metabolic enzyme htp [30]
Tco89 YPL180W 287, 288, 290 p-deletion Tco89 OUT Regulator TOR signaling dif [4]
Thr4 YCR053W 408 p-deletion Thr4 OUT Enzyme metabolic enzyme dif [11]
Tip41 YPR040W 79 p-deletion Tip41 OUT Regulator TOR signaling dif [4]
Tkl1 YPR074C 335 p-deletion Tkl1 OUT Enzyme metabolic enzyme htp [30]
Tkl1 YPR074C 335 p-mimic Tkl1 IN Enzyme metabolic enzyme htp [30]
Yap4 YOR028C 192, 196 p-deletion Yap4 OUT TF HOG pathway ch [19]
Zwf1 YNL241C 183, 188 p-deletion Zwf1 OUT Enzyme metabolic enzyme dif [11]
TF transcription factor, ch previously characterized phosphosite, dif phosphosite shown in previous phosphoproteomics studies to change in degree of
phosphorylation in different conditions, htp phosphosite detected in high throughput phosphoproteomics studies, no data on differential phosphorylation
aThe previously shown functionality of phosphorylation of Pfk2 S163 is potentially a result of increased expression from the plasmid used in that study (Additional
file 2: Figure S6)
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and Pbs2 showed varying effects under most conditions,
whereby the IN mutant was more strongly affected in both
proteins. The IN mutant of the kinase Pbs2 showed a very
similar behavior as its target Hog1 OUT, supporting the
hypothesis that phosphorylation of Pbs2 S508 inactivates
the protein, while in Hog1, phosphorylation of S174 and
T176 in the activation loop activates this kinase [15, 31, 32].
Overall, we retrieved three out of the 13 known phosphore-
gulated proteins under the tested conditions. Thus, growth
phenotypes provide strong evidence for phosphosite func-
tionality but would require testing of many conditions.





























Fig. 1 Growth phenotype of S. cerevisiae phosphomutants. a Example curves for analyzed growth traits of wild-type (green) and mutant (red). b
Growth phenotype in different growth conditions. Results that differ significantly from the wild-type are highlighted. Red and green boxes indicate
higher or lower results for the respective growth trait of the mutant compared to the wild-type. Black boxes indicate a general difference in shape.
Mutants with a growth phenotype are highlighted in blue. Abbreviations: μ: growth rate. CD: maximum cell density in one growth phase. L: lag
time. S: abnormalities in shape of growth curve
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Untargeted metabolomics reveals changes in
phenotypically silent phosphomutants
Next, we tested whether metabolic functionality of phos-
phosites whose genetic perturbation does not propagate
to physiological phenotypes could be identified by
untargeted metabolomics. Intracellular metabolites were
extracted with hot ethanol from exponentially growing
cultures in the four before used conditions using 96-well
cultivation. The extracts were injected into a Time Of
Flight mass spectrometer (TOF-MS) and metabolic
profiles in the m/z range of 50 to 1000 Dalton were
recorded [33]. Across all conditions, 122–259 ions were an-
notated to 183–342 metabolites using a genome-wide re-
construction model of S. cerevisiae [34] (Additional file 2:
Table S1). The data was processed to remove intensity drifts
during measurements and an OD-specific fold change was
calculated for every ion of each metabolic profile. The fold
changes of the replicates of one mutant were compared to
the fold changes of all other samples using a 2-sample t-test
and the median log2 fold change over all replicates was de-
termined. Ions with a corrected p-value < 10−3 and a |log2
fold change| > 0.3785 were considered as changing signifi-
cantly. The selected log2 fold change cutoff corresponds to
a 30% change and represents the 97.5% quantile across the
fold changes of all ions from the wild-type dataset (Add-
itional file 2: Figure S2A).
Typically, metabolite concentrations changed less
than two-fold in the phosphomutants (Additional file 2:
Figure S2B) and the majority of changes were in argin-
ine, proline, pyrimidine, purine or lysine metabolism
(Additional file 2: Figure S4). While 31% of the mutants
exhibited no significant (p-value < 10−3, |log2 fold
change| > 0.3785) metabolic response, most exhibited
changes in some metabolites, and five of the six mutants
with physiological phenotypes (Hog1 OUT, Pbs2 IN, Pda1
OUT, Pda1 IN and Tip41 OUT) showed changes in more
than 15 metabolites in at least one condition (Fig. 2a). In
many cases these broadly changing metabolic profiles
were presumably the consequence of altered growth rates
(Fig. 2b). Generally, phosphomutants with previously
characterized phosphosites featured more changes than
the unknown subset, suggesting that the latter contains
more nonfunctional sites (Fig. 2c). Metabolic profiles of
phosphosites with strong metabolic impact often showed
a tendency towards condition-specific effects, demonstrat-
ing the regulatory role of phosphosites under particular
conditions. Hog1 OUT for example showed broad effects
only when grown on pyruvate as the carbon source,
presumably because of the elevated osmotic stress in this
condition, and Tip41 showed almost exclusively effects
when growing on proline as sole nitrogen source (Fig. 2a).
Overall, our data suggest that metabolomics can detect
subtle consequences of deregulated phosphorylation that
is without detectable growth phenotypes.
Metabolic profile analysis indicates phosphosite
functionality
While we did not detect changes in direct reactants of
the 15 phospho-mutated enzymes after applying a strict
cutoff, we found metabolite changes for 12 mutants to
be enriched in specific pathways, suggesting phosphoryl-
ation to be functionally important for these pathways
(Additional file 4). For example, the OUT mutant of Yap4,
a transcription factor implicated in stress responses,
showed changes enriched in purine metabolism when
growing on glucose/glutamine (p-value 0.0007). Metabolic
effects of the Pda1 phosphomutants predominantly af-
fected arginine and proline metabolism (p-value 0.005 for
Pda1 IN and p-value 0.0004 for Pda1 OUT respectively in
glucose/NH4
+, p-value 0.0003 for Pda1 IN in glucose/glu-
tamine). A particularly clear case was Lys20, one of two
homocitrate synthase isoenzymes that catalyze the conver-
sion of oxoglutarate to homocitrate, the first step in lysine
biosynthesis. Lysine metabolism was found to be exclu-
sively enriched (p-value 0.006) in Lys20 OUT when grow-
ing on glucose/proline. While lysine biosynthesis is known
to be subject to transcriptional and allosteric control, it
was recently shown that Lys20 activity is also regulated by
phosphorylation [26, 35]. Metabolite responses in Lys20
OUT were observed only during growth on the poor ni-
trogen source proline and significant (p-value < 10−3, |log2
fold change| > 0.3785) changes were restricted to the final
pathway product lysine and its precursor saccharopine
(Fig. 3). Consistent with previous results [26], increased
lysine levels in Lys20 OUT suggest phosphorylation at
position S395/T396 to deactivate the enzyme. Since lysine
biosynthesis flux is rather low during slow growth on
proline, our data indicates that the pathway capacity is
down-regulated by phosphorylation in this condition.
To identify more global impact of phosphosites on me-
tabolism, we used two correlation approaches to analyze
the metabolic profiles. In the first, we correlated log2 fold
changes between all 496 possible mutant-pairs for each
condition. The correlation coefficients of all mutant-pairs
showed a normal distribution around 0, with a mean of
0.014 (Additional file 2: Figure S5A). The four correlation
coefficients from each mutant-pair were compared against
the distribution of all derived coefficients to identify sig-
nificantly correlation pairs. Five mutant-pairs correlated
significantly across the four conditions (p-value < 0.01),
suggesting these phosphosites to exhibit similar effects on
metabolism (Additional file 5). Two of these five pairs
were mutant variants of the same protein (Gln3 site1
OUT – Gln3 site2 OUT and Rim15 OUT – Rim15 IN),
emphasizing similar functionality of the introduced muta-
tions. Rim15 OUT, implicated in cell cycle regulation in
response to nutrient, and Pda1 IN were negatively corre-
lated in all conditions, whereby the strongest opposing
effects were largely in amino acid metabolism. The two
Raguz Nakic et al. BMC Systems Biology  (2016) 10:104 Page 5 of 15
other cases were Pfk2 OUT associating with Ste50 OUT
as well as Yap4 OUT.
In the second correlation, we quantified the similarity of
each mutant with itself across all four conditions to identify
phosphosite functionalities based on subtle but consistent
changes in metabolites across conditions. The correlation
coefficients of all condition-pairs showed an average above
zero, emphasizing that our phosphomutant set contains
mutants with condition-independent metabolic effects
(Additional file 2: Figure S5B). Out of the eight phospho-
mutants that were recovered in this analysis, we already
described strong metabolic changes predominantly under
one condition for three mutants (Pda1 OUT, Hog1 OUT
and Pbs2 IN, see Additional file 6). The calculated correl-
ation coefficients were particularly weak for Hog1 OUT
and Pbs2 IN. We suspect that despite the predominant
effects in specific conditions, this weak similarity is driven
by underlying subtle, but condition-independent, metabolic
changes. One such example in Pbs2 IN is the slight deple-
tion of glycerol across conditions, emphasizing the role of
Pbs2 in controlling glycerol accumulation via the HOG
pathway even under non-stress conditions [36]. Addition-
ally, the Gpd2 OUT, Gut1 OUT, Sko1 OUT and Lys20




Fig. 2 Overview on changing ions in metabolic profiles. a Number of changing ions of each mutant and condition. Only mutants with significantly
changing ions are depicted (|log2 fold change| > 0.3785 and p-value < 10−3). b Relation between number of changing ions and mutant growth rate.
c Distribution of changing ions in different mutant subclasses with no (none), little (1–4), intermediate (5–19) or many (>19) changing ions
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conditions. These mutants are cases without strong effects
under any tested condition, but with subtle condition-
independent changes, which suggest a possible fine-tuning
function of the phosphosites. The respective metabolites
driving condition-independent correlations were diverse,
e.g. affecting nucleotide metabolism in Gut1 OUT and ly-
sine in Lys20 OUT. As expected, we also recovered Pda1
IN that has effects throughout all conditions.
To systematically interpret the evidence for function-
ality of a given mutated phosphosite, we ranked the
functionality evidence based on a score that reflects the
number of changing ions, enriched pathways, correlation
with other mutants, and correlation with itself for each
phosphosite (Fig. 4). The number of changing ions was
scored between 0 and 3. The changes were classified as ei-
ther little (1–4 ions), affecting equal or less ions than in
the wild-type, where 4.75 ions were changing on average,
intermediate (5–19 ions), or many (>19 ions) changes, af-
fecting a broad part of metabolism with changes in > 10%
of all averagely detected ions. The growth condition with
the most changes was considered for scoring. The three
other aspects were scored between 0 and 2 according to
p-values. A score was attributed based on the most signifi-
cant p-value obtained in any growth condition. A p-value
of at least 10−2 was scored with a 1, while a p-value below
10−3 was scored with a 2. Supporting our approach, most
of the already characterized phosphosites scored very high
(Fig. 4). The three characterized cases with low scores can
be explained by incomplete mutation of all relevant phos-
phosites (e.g. Ste50) or lack of protein relevance under the
tested condition (e.g. Crz1 and Put3) [18, 37, 38]. Our data
suggests that the reported phosphoregulation of Pfk2 at
position S163 [11] resulted, at least in part, from a non-
endogenous increase of Pfk2 levels from the employed
plasmid construct (Additional file 2: Figure S6). Since we
cannot exclude that the reported phenotype of this Pfk2
variant originated from increased protein abundance, we
did not consider Pfk2 S163 as a known functional phos-
phosite and found only weak functionality evidence in the
Pfk2 IN mutant. Overall, the metabolomics data identified
most of the already characterized phosphosites as func-
tional with a total score of 3 or higher, one novel regula-
tory phosphosite with high confidence (Tip41 S79), and
several other novel functional phosphosites with lower
confidence. The much higher number of phosphosite
functionality identification by metabolomics compared to
Fig. 3 Metabolite level changes in lysine biosynthesis of the Lys20
OUT mutant growing on glucose/proline. Coloring indicates the
strength and direction of the fold changes. Significant fold changes
are highlighted with a bold frame (p-value < 10−3, absolute log2 fold
change > 0.3785). Metabolites in grey were not detected
Fig. 4 Phosphomutant functionality scoring based on metabolic profiles.
The number of changing ions was scored between 0 and 3 according to
the following scheme: 0 for no change; 1 for 1–4 changes; 2 for 5–19
changes; 3 for > 19 changes. The remaining three criteria were scored
between 0 and 2 based to on the strongest p-value: 0 for p-value > 10−2;
1 for p-value < 10−2; 2 for p-value < 10−3. Mutants exhibiting a growth
phenotype in the growth analysis are highlighted in blue
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growth phenotype analysis underlines the value of meta-
bolomics in assessing at least metabolic functionality. In
the next sections, we exploit the metabolomics data to
hypothesize specific functions for phosphosites in the
glycerol dehydrogenases Gpd1 and Gpd2, and the MAK
kinase Pbs2.
Phosphorylation of Pbs2 at S508 negatively regulates
Hog1 activity
Phosphorylation at position S514 and T518 activates the
MAPK kinase Pbs2, which in turn activates the Hog1
kinase in response to osmotic stress [28, 39] (Additional
file 2: Figure S7). Besides these two well-studies phos-
phosites, the here investigated S508 phosphosite was
suggested to be important for the inactivation of Pbs2
after adaptation to osmotic stress [15]. Our approach
scored both Pbs2 IN and its target Hog1 OUT as regu-
lated by phosphorylation (Fig. 4). The strongest meta-
bolic responses of both mutants occurred during growth
on pyruvate, presumably due to the osmotic stress of
increased sodium concentration in this medium. The
striking similarity of the Hog1 OUT and Pbs2 IN profiles
and the very different Pbs2 OUT profiles strongly
support the hypothesis that phosphorylation at position
S508 deactivates Pbs2, which causes reduced Hog1 activ-
ity (Fig. 5a and b).
We further investigated the presumably inactivating
role of S508 by exposing the Pbs2 mutants to elevated
concentrations of NaCl and monitored HOG pathway
activity by following Hog1 phosphorylation over time
(Fig. 5c). Consistent with the above reasoning, Pbs2 IN
failed to phosphorylate and activate Hog1 upon osmotic
stress. However, no delay in inactivation of Hog1 was
observed for Pbs2 OUT compared to wild-type dynam-
ics, suggesting that deactivation of Pbs2 was not
impaired in the Pbs2 OUT mutant. Since the HOG
signaling pathway is known to cross-talk with other
signaling pathways, we wondered whether phosphoryl-
ation of S508 had other physiological roles besides the
deactivation of Pbs2 after adaptation to osmotic stress.
One such interconnected pathway is the cell wall integ-
rity pathway [40, 41]. To test a link of Pbs2 S508 phos-
phorylation to cell wall integrity, we grew the mutants at
different temperatures to impose different cell wall stress
levels. We found that growth of Pbs2 OUT was exclu-
sively impaired at elevated temperatures, while Pbs2 IN
and Hog1 OUT showed growth defect most strongly
when growing at 16 °C (Fig. 5d). A change in cell wall
stress leading to conditional phenotypes of the Pbs2
phosphomutants suggests that phosphorylation of S508
is important for proper activation of HOG signaling
under specific cell wall stress conditions and plays a
critical role in the cross-talk between the two signaling
pathways.
Phosphorylation of Gpd1 and Gpd2 influences arginine
metabolism
The glycerol dehydrogenases Gpd1 and Gpd2 catalyze the
conversion of dihydroxyacetone phosphate to glycerol-3-
phosphate, the first step of glycerol synthesis. Although
Gpd1 and Gpd2 have distinct roles, they can at least par-
tially compensate for each other [42, 43]. In addition to
transcriptional regulation, both enzymes are subject to
phosphoregulation [11, 20]. In our screen, both glycerol
dehydrogenases were detected as regulated phosphopro-
teins, with Gpd2 OUT ranking slightly higher in the
metabolic profile analysis than Gpd1 OUT (Fig. 4).
Although we did not detect changes in the direct reactants
of either of the mutated isoenzymes, both OUT mutants
exhibited specific metabolic responses throughout most
conditions with an enrichment in arginine and proline
metabolism (p-value 0.002), in particular when growing
on proline as nitrogen source (Additional file 4). Unex-
pectedly, we detected the strongest changes in citrulline
and ornithine, along with some less pronounced changes
in arginine that we confirmed by targeted LC-MS/MS
measurements (Fig. 6a, b). The striking correlation of
Gpd2 OUT with itself across all conditions demonstrates
that this phosphoregulation is not specific to the proline
condition (Additional file 6).
How glycerol metabolism influences arginine metabol-
ism remains unclear. The OUT mutants have more
active glycerol dehydrogenases and hence generate more
G3P than the wild-type [11, 20], but neither of the
known routes from G3P connects to arginine metabol-
ism (Fig. 6c). Although the observed metabolite changes
suggest a possible blockage at Arg1 or Arg4 in the gly-
cerol dehydrogenases phosphomutants (Fig. 6a), the in-
fluence is more likely to occur indirectly via a regulatory
interaction. Previously, transcriptional and translational
regulation of arginine metabolism has been suggested to
be implicated in adaptation to osmotic stress [44]. In
our study, Pbs2 IN and Hog1 OUT, which have impaired
HOG signaling and cannot activate Gpd1 by dephos-
phorylation, showed strong changes mostly in arginine
but also citrulline upon osmotic stress (log2 fold change
arginine of 1.845 and 2.463 for Pbs2 IN and Hog1 OUT
respectively, see Additional files 7 and 8). These metabo-
lites change in opposite directions compared to the
Gdp1 OUT and Gpd2 OUT mutants where arginine is
decreased while citrulline is increased, supporting a
phosphorylation-dependent influence of the glycerol
dehydrogenases on arginine metabolism.
Discussion
The large networks of kinases and phosphatases represent
possibly the most complex post-translational regulation
system and play key roles in essentially all cellular pro-
cesses. Given the rapidly growing collection of reported
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phosphosites, a major limitation is assessing phosphosite
functionality and generating hypotheses on their precise
roles, at a scale and speed that matches the high-
throughput of modern mapping methods [2, 3, 5, 8, 12, 45].
Here we demonstrate that untargeted metabolomics of
point mutants with phospho IN or OUT modifications has
the potential to address this functionality problem. From
phosphosite mutants of 26 proteins involved in metabolism,
TOR and HOG signaling as a proof-of-concept, we were
able to recover 10 of the 13 positive controls by metabolo-
mics, compared to only three when relying on quantitative
growth assays. Importantly, metabolomics was able to
detect also more subtle metabolic effects that were pheno-
typically silent. The other three known phosphoproteins
were presumably not detected because we did not mutate
all relevant phosphosites (Ste50 OUT) or did not chose the
appropriate conditions that required activity of these
proteins (Crz1 OUTand Put3 OUT) [18, 37, 38].
Of the remaining 13 so far uncharacterized phospho-
sites, metabolomics provides evidence that those on
Cys3, Gln3, Gut1, Nbp2, Pfk2, Tco89 and Tip41 are
generally functional. At least Gln3 and Tip41 had been
suspected to be regulated by phosphorylation, although
no phosphosites were identified so far [46–48]. The
strongest evidence in our data was for S79 on Tip41, an
essential regulatory protein in TOR signaling whose
role upon activation of TOR is not yet clearly established




Fig. 5 Metabolic profiles, HOG signaling activation and phenotype of Pbs2 phosphomutants. a Log2 fold changes of all ions corresponding to
deprotonated metabolites of Hog OUT compared to Pbs2 IN in pyruvate/NH4
+ media. b Log2 fold changes of all ions corresponding to
deprotonated metabolites of Hog OUT compared to Pbs2 OUT in pyruvate/NH4
+ media. c Time course Western blot of Hog1 activity in wild-type
and Pbs2 phosphomutants, measured as phosphorylated Hog1 (P-Hog1) upon osmotic stress. Total Hog1 (t-Hog1) was measured as control.
d Phenotype analysis upon osmotic stress and exposure to different temperatures. Spotting assay of Pbs2 phosphomutants and Hog1 OUT in
synthetic complete (SC)-glucose, SC-glucose supplemented with 0.5 M NaCl, SC-glucose at 42 °C and SC-glucose at 16 °C. The assay was done
three times, the results of one exemplary experiment are shown
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growth on a poor nitrogen source suggests that S79 is
phosphorylated when the TOR complex is inactive and be-
comes dephosphorylated upon activation of TOR. Since
our recovery of positive controls was fairly good, we believe
that the newly tested phosphosites for which we could not
obtain functionality evidence are indeed mostly without
functional relevance. The employed, metabolomics-based
scoring system allowed classification of functionality, but
does not directly identify the regulatory consequences of
phosphorylation. Nevertheless, in several cases the metab-
olite profiles provided starting hypotheses for the specific
biological function without prior knowledge. For instance
accumulation of pathway end products suggested that
phosphorylation of Lys20, the first enzyme in lysine biosyn-
thesis, specifically regulates lysine pathway flux. The correl-
ation of Pbs2 IN and Hog1 OUT metabolite profiles
strongly suggested that the two phosphorylation events
have a similar function in mediating HOG signal flow.
However, changes in metabolism were not always intuitive
and possibly not direct consequences of the mutated phos-
phosites, as observed in the Gpd1 and Gpd2 mutants. The
main benefit of the metabolomics data in the process of
understanding phosphosite functionality is to point out
relevant cases efficiently, which can then be investigated in
more depth by other methods or in combination with
proteomics and transcriptomics data.
Even though about half of the tested phosphosites
appeared to be functional, most phosphomutants had no
detectable growth phenotype and exhibited relatively
modest metabolic changes, both in number and magni-
tude. This apparent resilience to point mutations does
not come entirely unexpected given that the much more
drastic intervention of 118 kinase and phosphatase dele-
tions in S. cerevisiae resulted in few detectable growth
phenotypes where only 26% of the mutants exhibited a
significant transcriptional response and about 40% had
a
b c
Fig. 6 Metabolite responses in arginine biosynthesis of the Gpd1 OUT and Gpd2 OUT mutants. a Metabolite response in arginine biosynthesis
under all tested conditions. Coloring indicates strength and direction of fold changes. Metabolites in grey were not detected in the respective
conditions. Metabolites without color boxes were not detected. b Quantification of arginine and citrulline levels by LC-MS/MS for Gpd1 OUT and
wild-type in glucose/NH4
+ medium. c Possible metabolic routes for G3P
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no detectable metabolite response [26, 50]. Several rea-
sons are likely to contribute to this robustness, including
the large overlap and redundancy both in kinase targets
and phosphosites on a given protein [2, 51–53]. Add-
itionally, adaptation to a new steady state in our experi-
ments will mask many direct regulatory effects and our
population-based measurements will have missed, for
example, cell cycle specific regulation events.
Conclusions
In this study, we investigated the potential of untargeted
metabolomics along with growth analysis to identify
functionality of phosphosites in a higher throughput.
While growth analysis was suitable to detect functional-
ity of a small number of phosphosites, metabolomics
allowed recovering most of the previously characterized
sites, along with some novel functional phosphosites and
aided in hypothesis generation on biological roles of
functionally relevant sites. Our results demonstrate the
potential of untargeted metabolomics to experimentally
identify functionality and conditional relevance of post-
translational modifications at high throughput to com-
plement current computational approaches [2, 52–55].
Methods
Strains used in this study
All phosphosite mutants were generated in S. cerevisiae
wild-type FY4 using the delitto perfetto method [21], the
oligonucleotides used in this study are listed in Additional
file 9. Briefly, in a first step, a cassette containing a positive
and a negative selection marker for growth on geneticin or
galactose containing media was amplified from pCORE-
Kp53 using primers with flanking region homologous to
the genomic region of the phosphosite of interest. The
cassette was inserted via homologous recombination into
the region of interest into wild-type FY4. Next, the entire
cassette was replaced via homologous recombination with
oligonucleotides containing the desired point mutation,
resulting in genomic point mutants of candidate phospho-
sites free of selection markers. Mutants were selected after
confirmation of proper integration of the desired mutation
by colony PCR and sequencing of the manipulated gen-
omic region +/− 200 base pairs. Up to three independent
mutant replicates per phosphosite were generated. Since
no differences in the metabolic profiles were observed be-
tween replicates of phosphomutants with strong metabolic
effects, the genetic approach was considered reliable and
data from untargeted metabolomics and growth phenotype
analysis of the replicates was merged for analysis.
Growth phenotype analysis
All strains were grown in phthalate-buffered Verduyn
minimal media supplemented with different carbon and
nitrogen sources [56]: glucose/NH4
+ media contained
20 g l−1 glucose and 5 g l−1 (NH4)2SO4, pyruvate/NH4
+
media contained 24.42 g l−1 sodium pyruvate and 5 g l−1
(NH4)2SO4, glucose/glutamine media contained 20 g l
−1
glucose, 5 g l−1 K2SO4 and 1 g l
−1 glutamine and glu-
cose/proline media contained 20 g l−1 glucose, 5 g l−1
K2SO4 and 1 g l
−1 proline.
Precultures with biological triplicates of each strain
were grown at 30 °C, 300 rpm, in deep 96-well plates in
1 ml of media, using one glass bead (Ø 4 mm) per well
to improve mixing efficiency. The preculture was used
for inoculation of microtiter plates at a starting optical
density of 595 nm (OD595) of 0.03. Growth was moni-
tored via light scattering using the Biolector® plate reader
at 30 °C, 1000 rpm. All experiments were run in dupli-
cates. The growth rate for all replicates was determined
by a linear fit to the log-transformed OD595 growth
curve. Maximum cell densities were determined as the
end point of growth at the entry of the stationary phase.
Clear outliers such as non-growing replicates and single
replicates with different growth signal e.g. due to tech-
nical reasons were removed manually. A two-sided 2-
sample t-test assuming unequal variance was performed
to compare the significance of difference in growth rate
and maximally reached cell density between mutants
and wild-type. The p-values were corrected for multiple
testing as described by Storey [57]. Growth rates or
maximally reached cell densities of at least 10% differ-
ence to the wild-type and a p-value < 10−3 were consid-
ered significant. Abnormal lag time and growth curve
shape were qualitatively assigned.
Metabolite extraction, sample measurement and data
processing for untargeted metabolomics
Metabolites were extracted from deep 96-well cultures
when the average OD595 of the plate was around 1 and
all cultures had doubled at least twice. The entire plates
was centrifuged for 1 min at −9 °C, 4000 rpm. The
supernatant was discarded, 150 ul of 80 °C 75% (v/v)
ethanol in 10 mM ammonium acetate at pH 7.5 was
added to each well. For extraction, plates were incubated
for 5 min at 80 °C with three vortexing steps. The plates
were centrifuged again for 5 min and the supernatant
containing the metabolites was transferred to fresh
plates for analysis. The metabolite extraction and mea-
surements of extracts were conducted in two batches of
mutants (Additional file 1). Mutants were grown in trip-
licates on the 96-well plate while wild-type was inocu-
lated in four to five replicates per plate. Each culture
plate was grown and extracted twice on different days
yielding to day replicates for every mutant.
Metabolites were measured by direct flow double
injection of extracts on an Agilent 6550 series quadru-
pole TOF MS with the help of a GERSTEL MPS2. Ions
within a mass/charge ratio range of 50–1000 were
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measured [33]. The ions were annotated either using the
genome-wide reconstruction model of S. cerevisiae
metabolism by Dobson et al. (2010) or, for pathway
enrichment analysis, the S. cerevisiae reactants defined
in the KEGG database [34, 58]. Only ions corresponding
to deprotonated metabolites were considered for further
analysis. The entire annotation is provided in Additional
file 10. All data analysis was conducted using Matlab
(The Mathworks, Natick).
Measured ion intensities of samples taken at the
exponential phase were corrected for potential signal
drifts during the measurement run by applying locally
weighted scatter plot smoothing (LOWESS). For further
processing and retrieval of changes in metabolites only
samples in a restricted OD595 range between 0.6 - 1.7,
with marginal variation between conditions and sam-
pling batches, were considered. This OD range con-
tained the majority of all exponentially growing samples.
A fitted intensity curve was used as OD-wise reference
curve to compare each ion of every sample to the aver-
age intensity at its specific sampling OD. This OD-wise
comparison allows to account for potential impacts of
the extraction OD on ion intensity and comparison of
samples with different extraction ODs. Fitting was done
by smoothing the measured intensities of all samples vs.
the OD595 of the samples using LOWESS. Including all
samples for the calculation of the reference curve
enables a thorough covering of the entire OD range and
renders the reference curve robust. Further, LOWESS
was performed in robust mode to prevent individual
strong metabolic changes from having a dominating
impact on the reference curve. An adapted procedure
for the calculation of the OD-wise reference curve was
chosen for batch 2, as the number of Pda1 OUT and
Pda1 IN mutant strains strongly dominated this batch,
being the only mutants generated in three replicates in
batch 2. Therefore, three Pda1 OUT and three Pda1 IN
replicates were chosen randomly from each of the two
deep 96-well plate replicate for the calculation of the
reference curve, thereby adapting the number of repli-
cates for this mutant to the remaining phosphomutants
in batch 2. Random sample choice was done 1000 times,
and the final reference curve for batch 2 was calculated as
the median of the references curves of all permutations.
For every ion we determined the fold change com-
pared to the intensity of the ion-specific reference curve
at the corresponding sample-OD. Fold changes for all
samples of each mutant were pooled and ion-wise out-
liers that deviate more than two standard deviations
from the mean fold change were excluded. The median
log2 fold change was determined and a p-value was
assigned by comparing the fold changes of one mutant
to all other samples using a two-sided 2-sample t-test as-
suming unequal variance (Additional files 7 and 8). The
p-values were corrected for multiple testing as described
before [57]. A cutoff on the fold change was applied for
removal of very small changes. For this purpose, the
absolute log2 fold changes of all wild-type ions were
pooled, and the 97.5% quantile was determined to be at
0.381. Accordingly, corresponding to a 30% change, the
log2 fold change cutoff was defined at 0.3785. Ions with a
log2 fold change stronger than +/−0.3785 and a corrected
p-value < 10-3 were considered significantly changing.
Analysis of untargeted metabolomics data
Pathway enrichment analysis was performed based on the
approach detailed in Kühne et al. (2015) [59]. Briefly, me-
tabolites passing a relaxed cutoff (p-value 0.1 and absolute
log2 fold change of 0.1375, corresponding to a 10% change)
were sorted according to their absolute change, and a
hypergeometric test was performed to calculate the enrich-
ment of each metabolic pathway. For the enrichment calcu-
lation, the hit subset was defined starting with only the top
hit of the generated list of sorted metabolites. For each sub-
sequent enrichment analysis, the hit subset was extended
by adding the next metabolite from the sorted list. Eventu-
ally the most significant result of all generated enrichments
based on the different hit subsets was considered. Pathway
definition was retrieved from KEGG [58]. Ions that were
annotated to several metabolites within a given metabolic
pathway were lumped to one entry.
To retrieve the mutant-pair correlation over all condi-
tions, a pair-wise Pearson correlation coefficient was calcu-
lated for all mutant-pairs for each condition. Calculation
was based on log2 fold changes of ions corresponding to
deprotonated metabolites. The correlation coefficients of all
mutant-pairs showed a normal distribution that centered
around 0 (Additional file 2: Figure S5A). The four correl-
ation coefficients from each mutant-pair were compared
using a 2-sample t-test against this distribution of correl-
ation coefficients of all remaining mutant-pairs in order to
find meaningful mutant-pair correlations. Mutant-pairs
with a p-value below 0.01 were considered as correlating
significantly with each other throughout all conditions. For
analyzing self-correlation of mutants across conditions, the
pair-wise Pearson correlation coefficient was calculated for
each mutant for every condition-pair combination, result-
ing in six correlation coefficients per phosphomutant.
Calculation was based on log2 fold changes of ions corre-
sponding to deprotonated metabolites. The six correlation
coefficients of each mutant were compared against an aver-
age of zero performing a t-test. Mutants with a p-value
below 0.01 were considered as correlating significantly with
themselves across conditions.
Targeted LC-MS/MS analysis
For targeted LC-MS/MS analysis, 500 ml shake flasks
containing 50 ml glucose/NH4
+ medium were inoculated
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with overnight precultures grown in the same medium.
At OD595 1 +/− 0.15, 1 ml of culture was quenched by
mixing with 4 ml 60% (v/v) methanol precooled at -40 °C.
100 ul uniformly-labeled 13C yeast extract was added
as internal standard and metabolites from cell pellets
were extracted by incubation with 1 ml 75% (v/v) 80 °C
ethanol for 3 min, with three vortexing steps. Samples
were dried and resuspended in MilliQ water and ana-
lyzed for quantitative targeted analysis of specific metab-
olites as described before with the exception that
citrulline was normalized to the 13C-arginine signal for
lack of 13C-citrulline signal in the standard [60]. Mean
and standard deviation of three wild-type and four
Gpd1 OUT replicates was determined.
Spotting assay
Yeast cells from SC-galactose plates were dissolved in
0.9% (w/v) NaCl and OD595 was adjusted to 1. Serial
1:10 dilutions were prepared and 3.5 ul were spotted
onto SC-glucose plates with or without 0.5 M NaCl.
Plates without NaCl were incubated at 16 °C, 30 °C or
42 °C, while plates with NaCl were incubated at 30 °C
for 2–4 days.
Hog1 phosphorylation analysis in the Pbs2 mutants
Yeast strains were grown in YPD at 30 °C to an OD660
of 0.6. Cells were stressed with NaCl (final concentration
0.4 M) and samples were taken at the indicated time
points. Proteins were extracted by glass bead lysis, sepa-
rated on a 10% (w/v) SDS page and transferred to a
PVDF membrane. The membrane was probed with anti-
ph-p38 (Cell Signaling 9215 L) and anti-total Hog1
(Santa Cruz Biotechnology sc6815).
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